Allianz Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-243,816
| Closed | -$17.6M | – | 2372 |
|
|
2020
Q4 | $17.6M | Buy |
243,816
+50,220
| +26% | +$2.63M | 0.02% | 661 |
|
|
2020
Q3 | $8.82M | Buy |
193,596
+44,584
| +30% | +$1.86M | 0.01% | 806 |
|
|
2020
Q2 | $6.73M | Buy |
149,012
+59,177
| +66% | +$2.65M | 0.01% | 1065 |
|
|
2020
Q1 | $3.46M | Sell |
89,835
-41,718
| -32% | -$1.92M | ﹤0.01% | 1318 |
|
|
2019
Q4 | $6.09M | Buy |
131,553
+24,269
| +23% | +$1.05M | 0.01% | 1387 |
|
|
2019
Q3 | $4.37M | Sell |
107,284
-76,839
| -42% | -$3.32M | ﹤0.01% | 1510 |
|
|
2019
Q2 | $8.87M | Buy |
184,123
+15,575
| +9% | +$819K | 0.01% | 1245 |
|
|
2019
Q1 | $10.6M | Sell |
168,548
-5,492
| -3% | -$377K | 0.01% | 1125 |
|
|
2018
Q4 | $10.4M | Sell |
174,040
-13,978
| -7% | -$839K | 0.01% | 1091 |
|
|
2018
Q3 | $12.1M | Sell |
188,018
-63,415
| -25% | -$3.54M | 0.01% | 1176 |
|
|
2018
Q2 | $11.3M | Sell |
251,433
-223,094
| -47% | -$8.9M | 0.01% | 1202 |
|
|
2018
Q1 | $14.7M | Sell |
474,527
-51,684
| -10% | -$1.7M | 0.01% | 1050 |
|
|
2017
Q4 | $15.7M | Buy |
526,211
+98,752
| +23% | +$2.86M | 0.01% | 1097 |
|
|
2017
Q3 | $14.1M | Sell |
427,459
-205,077
| -32% | -$7.1M | 0.01% | 1149 |
|
|
2017
Q2 | $21.2M | Sell |
632,536
-128,596
| -17% | -$3.84M | 0.02% | 937 |
|
|
2017
Q1 | $22M | Buy |
761,132
+371,114
| +95% | +$9.19M | 0.02% | 963 |
|
|
2016
Q4 | $8.72M | Sell |
390,018
-140,767
| -27% | -$2.75M | 0.01% | 1419 |
|
|
2016
Q3 | $9.86M | Sell |
530,785
-37,278
| -7% | -$703K | 0.01% | 1335 |
|
|
2016
Q2 | $9.26M | Sell |
568,063
-259,414
| -31% | -$3.82M | 0.01% | 1269 |
|
|
2016
Q1 | $9.66M | Sell |
827,477
-36,640
| -4% | -$409K | 0.01% | 1147 |
|
|
2015
Q4 | $10.1M | Buy |
864,117
+12,100
| +1% | +$153K | 0.01% | 1048 |
|
|
2015
Q3 | $10.4M | Buy |
852,017
+428,638
| +101% | +$5.46M | 0.01% | 977 |
|
|
2015
Q2 | $3.99M | Sell |
423,379
-11,202
| -3% | -$104K | ﹤0.01% | 1454 |
|
|
2015
Q1 | $3.85M | Sell |
434,581
-43,678
| -9% | -$441K | ﹤0.01% | 1324 |
|
|
2014
Q4 | $4.8M | Buy |
478,259
+21,524
| +5% | +$185K | 0.01% | 1232 |
|
|
2014
Q3 | $3.06M | Sell |
456,735
-32,829
| -7% | -$230K | ﹤0.01% | 1269 |
|
|
2014
Q2 | $3.51M | Sell |
489,564
-14,012
| -3% | -$112K | ﹤0.01% | 1029 |
|
|
2014
Q1 | $5.08M | Buy |
503,576
+72,113
| +17% | +$664K | 0.01% | 954 |
|
|
2013
Q4 | $3.43M | Buy |
431,463
+154,713
| +56% | +$1.44M | ﹤0.01% | 1056 |
|
|
2013
Q3 | $2.74M | Buy |
+276,750
| New | +$2.18M | ﹤0.01% | 1100 |
|
Other funds holding BEAT
Allianz Asset Management's BEAT Position: Q1 2021 in Review
Allianz Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 243,816 shares — an estimated $17.6M sold.
Allianz Asset Management first reported a position in BEAT in Q3 2013 and held it in 30 quarters. The position peaked at $22M in Q1 2017. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Allianz Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Allianz Asset Management sold 243,816 BioTelemetry, Inc. shares in Q1 2021, an estimated $17.6M.
- Allianz Asset Management first reported a position in BioTelemetry, Inc. in Q3 2013 and held it in 30 quarters.
- Allianz Asset Management's BioTelemetry, Inc. position peaked at $22M in Q1 2017.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Allianz Asset Management's 13F filing for Q1 2021, filed 13 May 2021.